ab

Ameris Ban

ABCB
NYSE
$84.84

How predictable is Ameris Ban's business?

Ameris exhibits relatively steady growth and profitability across rate cycles. TTM diluted EPS approximates $6.36 (Q2‑25 through Q1‑26), with ROA ~1.6% and ROTCE ~14–15% in Q1 2026. Credit remains benign: ACL 1.62% of loans, NPA ~0.45% of assets (0.33% ex‑GNMA) and NCOs ~0.21% annualized.

Deposits and loans grew mid‑single digits annualized in Q1 2026. Offsets: fee income from mortgage can be variable with rates, and CRE exposure requires ongoing governance. Diversification into mortgage warehouse, SBA and premium finance helps, but macro and regulatory factors can swing outcomes more than in toll‑like businesses.